Is Migraine Primarily a Metaboloendocrine Disorder?
- 79 Downloads
Purpose of the Review
The goals of this review are to evaluate recent studies regarding comorbidity between migraine and different metabolic and endocrine disorders and to discuss the role of insulin resistance as a common pathogenetic mechanism of these diseases.
Recently, several studies showed that migraine is associated with insulin resistance, a condition in which a normal amount of insulin induces a suboptimal physiological response. All the clinical studies that used the oral glucose tolerance test to examine insulin sensitivity found that, after glucose load, there is in migraine patients a significant increase of both plasmatic insulin and glucose concentrations in comparison with controls. On the contrary, no association was found between migraine and type 2 diabetes, while type 1 diabetes seems to have a protective effect in the disease. Obesity and hypertension were shown to be risk factors for both episodic and chronic migraine. Metabolic syndrome has been recently associated mainly with migraine with aura and is now considered a risk factor also for medication overuse headache. Finally, a bidirectional association between migraine and hypothyroidism has been recently demonstrated, suggesting that common genetic or autoimmune mechanisms underlie both diseases.
Recent studies showed that insulin receptor signaling and the related physiological responses are altered in migraine and may have a relevant pathogenic role in the disease. Further studies are warranted in order to better elucidate mechanisms underlying insulin resistance in migraine in order to develop new therapeutic strategies for this debilitating disease.
KeywordsMigraine Insulin resistance Obesity Metabolic syndrome Hypothyroidism
Compliance with Ethical Standards
Conflict of Interest
I. Rainero declares grant support from the Horizon-2020 project and serves on the Editorial Board of Journal of Headache and Pain. Govone F., Gai A., Vacca A., and Rubino E. declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 21.Cavestro C, Bedogni G, Molinari F, Mandrino S, Rota E, Frigeri MC. Alpha-lipoic acid shows promise to improve migraine in patients with insulin resistance: a 6-month exploratory study. J Med Food 2017; https://doi.org/10.1089/jmf.2017.0068.
- 26.Hagen K, Åsvold BO, Midthjell K, Stovner LJ, Zwart JA, Linde M. Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Trøndelag health surveys 1995-1997 and 2006-2008. Cephalalgia. 2018;38:417–26.Google Scholar
- 27.Fazeli Farsani S, Souverein PC, van der Vorst MM, Knibbe CA, de Boer A, Mantel-Teeuwisse AK. Chronic comorbidities in children with type 1 diabetes: a population-based cohort study. Arch Dis Child 2015;100:763–8.Google Scholar
- 36.Domínguez C, Vieites-Prado A, Pérez-Mato M, Sobrino T, Rodríguez-Osorio X, López A, Campos F, Martínez F, Castillo J, Leira R. Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia. 2017. https://doi.org/10.1177/0333102417731351
- 39.Bond DS, Thomas JG, Lipton RB, Roth J, Pavlovic JM, Rathier L, et al. Behavioral weight loss intervention for migraine: a randomized controlled trial. Obesity (Silver Spring). 2018;26:81–7.Google Scholar
- 51.Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–97.Google Scholar
- 52.Alberti KG, Alberti KG, Zimmet P, Shaw J, IDF Epidemiology 684 Task Force Consensus Group. The metabolic syndrome—a new 685 worldwide definition. Lancet. 2005;366:1059–62.Google Scholar
- 53.Headache Classification Sub-Committee of the International Headache Society. International classification of headache disorders, 2nd edition. Cephalalgia. 2004;24:1–160.Google Scholar